Hypertension: know what is behind your numbers 

Bitte beachten Sie, dass dieser Artikel derzeit nur auf Englisch verfügbar ist. Eine Übersetzung ins Deutsche wird in Kürze verfügbar sein.

• Stoffwechselkrankheiten
• Abteilung für Kardiovaskuläre Forschung

CVRU publishes an informative brochure for the public

High blood pressure (HBP) or hypertension is often called the ‘‘silent killer’’, due to the lack of obvious symptoms indicating its presence. It is therefore important to be able to self-monitor one’s blood pressure and understand how to interpret the measurements. To this end, the Cardiovascular Research Unit (CVRU) of the LIH Department of Population Health (DoPH) recently published an informative brochure to help shed light into cardiovascular health.         

The Cardiovascular Research Unit, led by Dr Yvan Devaux, is deeply involved in the characterisation of the mechanisms of cardiovascular diseases, with the aim of developing novel diagnostic and therapeutic approaches to treat these conditions in a personalised and gender-specific way.

In addition to its participation in large European-funded consortia, notably the EU-CardioRNA COST Action CA17129 and the COVIRNA innovation action financed by COST association (Cooperation in Science and Technology) and the EU Horizon 2020 research and innovation programme, CVRU is also actively engaged in the dissemination of its research results to tangibly improve patient health.

In this context, Dr Amela Jusic, postdoctoral fellow of the CVRU team, released a practical brochure to inform about the risks associated with hypertension and her research activities dedicated to improving the understanding of the significance of this disease. The brochure explains some of the key factors that may lie behind the onset of high blood pressure, reviews novel approaches in the diagnosis of hypertension, brings forward some of the potential consequences that may result from this condition and suggests concrete steps to prevent its onset.

The brochure, which will be widely disseminated to the public, is endorsed by the Luxembourg Ministry of Health and the Fondation du Coeur Daniel Wagner, and is available here.